You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Dosing and administration of
Relvar Ellipta

Asthma

COPD

Relvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate:

  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonists
  • Patients already adequately controlled on inhaled corticosteroid steroids and long-acting beta2-agonist

Relvar Ellipta is indicated for the symptomatic treatment of adults with COPD with a FEV1

<70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy.

Dosing for asthma

Dosing for COPD

Inhaled once daily

92/22 mcg,184/22 mcg

Inhaled once-daily

92/22 mcg only

How to use the Ellipta Inhaler

Only open the package when you are ready to begin using your inhaler. Once you tear open the foil you should use your Ellipta inhaler within 6 weeks. The “Discard by” date should be written on the inhaler label in the space provided. The “Discard by” date is 6 weeks from the date of opening the tray. After this date the inhaler should no longer be used. The tray can be discarded after first opening.

Open:

1. Slide the cover down until you hear a ‘click’

2. While holding the inhaler away from your mouth, breathe out as far as is comfortable

relvar-open

Inhale:

1. Put the mouthpiece between your lips, and close your lips firmly around it

2. Take one long, steady, deep breath in and hold this breath for at least 3-4 seconds

relvar-inhale

Close:

1. Remove the inhaler from your mouth and breathe out slowly and gently

2. Slide the cover upwards as far as it will go to cover the mouthpiece

3. If you want to clean the mouthpiece, use a dry tissue, before cleaning the cover

4. Rinse your mouth with water after using the inhaler, do not swallow

close-relvar

Order a demonstration Ellipta inhaler

IMPORTANT: The demonstration Ellipta inhaler is intended for demonstrating how to use the Ellipta inhaler for patients, not for patient use. Patients should not put the demonstration inhaler in their mouth.

How to use the Ellipta inhaler video

Watch our short video on how to use the Ellipta inhaler.

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/Ireland/MP4/ellipta_how_to_video.mp4

Note: The Ellipta demonstration inhaler should be replaced once the dose counter reaches zero. 

Getting Started

Before your patient starts using their active inhaler, you should consider the following:

The Ellipta inhaler is packaged in a tray containing a dessicant gel sachet, which should be thrown away with the other packaging.

When it is taken out of the tray, the inhaler will be in the ‘closed’ position (the cover will be shut). It is ready to use straight from the packaging, so there is no need to prepare it for use in any special way. 

IMPORTANT: If your patient opens and closes the cover of their inhaler without inhaling the medicine, the dose will be lost. Your patient should be ready to take the medicine before opening the cover.

Top tips for your patients

  • It may not be possible to taste or feel the medicine, even when using the inhaler correctly
  • Do not shake the inhaler, block the air vents with your fingers, or breathe out into the inhaler
  • The dose counter will count down by one unit at a time. If the dose counter does not count down when you hear the ‘click’, the inhaler will not deliver the required dose. If this happens, your patient should take the inhaler back to the pharmacy.

RELVAR Ellipta was developed in collaboration with INNOVIVA Inc.

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies